The Role of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Renal Cell Carcinoma (RCC) Treated with ICIs–TKIs: A Retrospective Multicentric Study
In our study, SBRT for oligoprogressive mRCC turned out to be a safe and useful treatment which was able to preserve current treatment. Further prospective studies are necessary to explore the effects of the ICIs-TKIs combination and SBRT upon oligoprogressive sites in mRCC.
Authors
- Ivan Fazio
- Dario Aiello (ORCID: https://orcid.org/0000-0002-3894-7457)
- Maria La Vecchia (ORCID: https://orcid.org/0000-0002-3953-630X)
- Antonella Mazzonello
- Valentina Zagardo
- Tiziana Bruno (ORCID: https://orcid.org/0000-0003-0352-4523)
- Leonarda La Paglia
- Manuela Federico (ORCID: https://orcid.org/0009-0005-0241-5466)
- Lorella Testa
Publication Details
- Journal
- Journal of Personalized Medicine
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3390/jpm14101030
- Citations
- 2
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84